ERNA Stock Analysis: Buy, Sell, or Hold?
ERNA - Ernexa Therapeutics Inc. Common Stock
$12.04
-1.59 (-11.67%)
▼
5d:
+66.99%
30d:
+5694.03%
90d:
+3547.38%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When ERNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
19 traders called ERNA this week
94% bullish • 2 bearish
94% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ERNA is 68.4% above its trading range ($7.15). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ERNA is 68.4% above its trading range ($7.15). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ERNA is currently trading at $12.04, which is considered extended relative to its 30-day fair value range of $-1.34 to $7.15.
Technical Outlook: Technically, ERNA is in a uptrend. Immediate support is located at $3.80, while resistance sits at $15.88. Short-term momentum is weak, with the stock down 11.7% recently.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+120.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ERNA is in a uptrend. Immediate support is located at $3.80, while resistance sits at $15.88. Short-term momentum is weak, with the stock down 11.7% recently.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+120.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-1.34 -
$7.15
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Price significantly overextended (+68.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-11.7%)
- BULLISH: Trading 120.1% below Wall St target ($30.00)
Trading Range Analysis
30-Day Trading Range
$-1.34 -
$7.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.80
Resistance Level
$15.88
Current Trend
Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.55
Wall Street Target
$30.00
(+120.1%)
Revenue Growth (YoY)
-94.1%
Share & Embed Analysis
Last updated: May 18, 2026 1:19 PM ET
Data refreshes hourly during market hours. Next update: 2:19 PM
Data refreshes hourly during market hours. Next update: 2:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
